Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anti-abuse drug delivery
Pharma
Vallon's abuse-resistant Adderall fails clinical trial
ADAIR diid no better than the reference formulation of the stimulant dextroamphetamine on a measure of abuse liability, causing the trial to fail.
Nick Paul Taylor
Mar 22, 2022 7:35am
Reworked OxyContin hasn't reduced opioid abuse, FDA panel says
Sep 21, 2020 12:58pm
Endo's Opana faces FDA action after panel's vote
Mar 15, 2017 9:40am
Grunenthal insists crush-proof tablet works after Endo pulls Opana sNDA
Aug 30, 2016 9:28am
